STOCK TITAN

Braskem (BAK) shareholders back broad bylaw and governance changes in June 2026 votes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Braskem S.A. filed a Form 6-K presenting the final synthetic voting map from its ordinary and extraordinary general meetings held on June 8, 2026. Shareholders strongly approved extensive amendments to the bylaws to improve wording and align articles with a new Shareholders' Agreement and updated governance practices, including formalizing several board committees. They also approved consolidating the bylaws and authorizing the Board of Directors to align the Executive Board’s term with the new board term. Proposals related to cumulative and separate voting for the Board of Directors drew comparatively low support, indicating limited shareholder demand for these mechanisms. The filing also reiterates standard cautionary language on forward-looking statements and litigation and pandemic-related uncertainties.

Positive

  • None.

Negative

  • None.
Item 1 approvals 438,762,275 shares Amendment of multiple bylaw articles; 84.9% of share capital
Item 2 approvals 135,316,734 shares Amendments tied to new Shareholders' Agreement; 84.6% of share capital
Item 3 approvals 441,490,301 shares Consolidation of bylaws; 87.6% of share capital
Item 4 approvals 441,490,202 shares Authorize early end of current Executive Board term; 87.6% of share capital
Item 6 approvals 135,939,794 shares Nomination of full board slate; 85.1% of share capital
Item 14 approvals 129,887,310 shares Replacement of Fiscal Council members; 83.8% of share capital
Disregarded remote votes 2,828,193 common; 15,103,418 preferred Prior instructions disregarded on items 1, 2 and 14 after proposal adjustments
Shareholders' Agreement financial
"to reflect the provisions of the new Shareholders' Agreement, pursuant to the Material Fact"
cumulative voting financial
"Do you wish to request the cumulative voting for the election of the board of directors"
A voting system for electing a company's board where each shareholder can pool all their votes and cast them for one or more board candidates rather than spreading votes evenly. Think of it like having 100 stickers you can put all on one favorite class representative instead of giving one sticker to each candidate. It matters to investors because it gives minority holders a realistic chance to secure board representation and influence company decisions, affecting governance, strategy and therefore investment value.
Ordinary General Meeting financial
"Items on the agenda of the Ordinary General Meeting held on June 8, 2026"
Statutory Compliance and Audit Committee – CAE financial
"simplification of the statutory discipline of the Statutory Compliance and Audit Committee – CAE"
forward-looking statements financial
"This report on Form 6-K may contain forward-looking statements within the meaning"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Brazilian Corporation Law financial
"under the terms of art. 141 of Law 6,404, of 1976"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


For the month of June, 2026

(Commission File No. 1-14862 )

 


 

BRASKEM S.A.

(Exact Name as Specified in its Charter)

 

N/A

(Translation of registrant's name into English)

 


 

Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil

(Address of principal executive offices)

 


 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

 

 
 
 

 

BRASKEM S.A

C.N.P.J. No. 42.150.391/0001-70

NIRE 29300006939

PUBLICLY HELD COMPANY

 

FINAL SYNTHETIC VOTING MAP

 

Items on the agenda of the Ordinary General Meeting held on

June 8, 2026

 

 

Resolution code Description of the resolution Resolution vote Number of shares (%) of Share Capital (%) of the Total Number of Ordinary Shares (%) of the Total Number of Preference Shares
Number of Shares (Ordinary) Number of Shares (Preferred)
Extraordinary General Meeting
Amendment of articles 1, 2, 4, 6, 7, 9, 10, 13, 15, 16, 24, 34, 35, 39, 42, 43, 45, 46, 47, 48, 50, 51 and 52, to improve, clarify and ensure consistent wording, renumbering and adjustments of cross-references. APPROVALS 438,762,275 137,565,702 84.9% 99.4% 58.0%
REJECTIONS - 13,052 0.0% 0.0% 0.0%
ABSTENTIONS - 462,824 0.1% 0.0% 0.2%
 
1 
 
 

 

Amendment of articles 11, 12, 14, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 28, 29, 30, 31, 32, 33, 36, 37, 38, 40, 41, 44 and 49, to reflect the provisions of the new Shareholders' Agreement, pursuant to the Material Fact of April 23, 2026, and the new governance practices and improvements to be implemented,  including the extension of the minimum period for convening and reviewing the list of competencies of the general meeting, the rules related to the composition, operation and list of competencies of the Board of Directors and the Executive Board, the incorporation into the bylaws of the Finance and Investment Committee; Strategy, Sustainability and Communication Committee; People and Organization Committee; Safety, Environment and Health Committee (SMS), which are thus also statutory; in addition to the simplification of the statutory discipline of the Statutory Compliance and Audit Committee – CAE, as well as to improve the wording and consistency adjustments with other changes. APPROVALS 438,762,275 135,316,734 84.6% 99.4% 57.1%
REJECTIONS - 2,259,800 0.3% 0.0% 1.0%
ABSTENTIONS - 465,044 0.1% 0.0% 0.2%
 
2 
 
 

 

3 Due to the changes resolved in the items above, to resolve on the consolidation of the Company's Bylaws, including renumbering articles and paragraphs as applicable. APPROVALS 441,490,301 152,872,135 87.6% 100.0% 64.5%
REJECTIONS 10 19,904 0.0% 0.0% 0.0%
ABSTENTIONS 100,157 252,942 0.1% 0.0% 0.1%
4 Once the amendment to the bylaws of the term of office of the Board of Executive Officers contained in item 1.2 of the agenda of the Management Proposal is approved, authorize the Board of Directors of the Company to anticipate the end of the current term of office of the Executive Board (until 2027) and the beginning of a new term of office of two (2) years, in order to coincide with the term of office of the Board of Directors started as of the election at the AGM of 29 April 2026. APPROVALS 441,490,202 152,863,684 87.6% 100.0% 64.5%
REJECTIONS 109 46,540 0.0% 0.0% 0.0%
ABSTENTIONS 100,157 234,759 0.0% 0.0% 0.1%
5 Do you wish to request the cumulative voting for the election of the board of directors, under the terms of art. 141 of Law 6,404, of 1976? (If the shareholder chooses "no" or "abstain", his/her shares will not be computed for the request of the cumulative voting request). APPROVALS 2,727,917 3,536,119 0.9% 0.6% 1.5%
REJECTIONS 120 10,100,936 1.5% 0.0% 4.3%
ABSTENTIONS 100,157 16,451,496 2.4% 0.0% 6.9%
 
3 
 
 

 

6 Nomination of all the names that compose the slate (the votes indicated in this section will be disregarded if the shareholder with voting rights fills in the fields present in the separate election of a member of the board of directors and the separate election referred to in these fields takes place). - Eleição Majoritária APPROVALS 441,483,130 135,939,794 85.1% 100.0% 57.3%
REJECTIONS 7,110 16,236,345 2.4% 0.0% 6.8%
ABSTENTIONS 100,228 968,844 0.2% 0.0% 0.4%
7 If one of the candidates that composes your chosen slate leaves it, can the votes corresponding to your shares continue to be conferred on the same slate? APPROVALS 2,720,956 11,215,694 1.7% 0.6% 3.2%
REJECTIONS 7,009 17,734,401 2.2% 0.0% 5.1%
ABSTENTIONS 100,228 1,138,958 0.2% 0.0% 0.3%
 
4 
 
 

 

8 In case of a cumulative voting process, should the corresponding votes to your shares be equally distributed among the members of the slate that you´ve chosen? [If the shareholder chooses ”yes” and also indicates the ”approve” answer type for specific candidates among those listed below, their votes will be distributed proportionally among these candidates. If the shareholder chooses to ”abstain” and the election occurs by the cumulative voting process, the shareholder's vote shall be counted as an abstention in the respective resolution of the meeting.] APPROVALS 2,728,006 421,734 0.4% 0.6% 0.1%
REJECTIONS - 300 0.0% 0.0% 0.0%
ABSTENTIONS 100,187 14,681,371 1.9% 0.0% 4.2%
10 Do you wish to request a separate election of a member of the board of directors, under the terms of article 141, paragraph 4, I, of Law 6,404, of 1976? (The shareholder can only fill this field in case of keeping the position of voting shares ininterrupted for 3 months prior to the general meeting. If the shareholder chooses “no” or “abstain”, his/her shares will not be computed for the request of a separate election of a member of the board of directors). APPROVALS 8,547 - 0.0% 0.0% 0.0%
REJECTIONS 2,718,881 - 0.3% 0.6% 0.0%
ABSTENTIONS 100,558 - 0.0% 0.0% 0.0%
11 If it is found that neither the holders of voting shares nor the holders of non-voting preferred shares or those with restricted voting rights have complied, respectively, with the quorum required in items I and II of paragraph 4 of article 141 of the Brazilian Corporation Law, you wish that your vote be aggregated to the votes of the non-voting shares in order to elect to the Board of Directors the candidate with the same number of votes. the highest number of votes among all those who, appearing in this Ballot, run for election separately? APPROVALS 2,727,577 - 0.4% 0.6% 0.0%
REJECTIONS 359 - 0.0% 0.0% 0.0%
ABSTENTIONS 100,257 - 0.0% 0.0% 0.0%
 
5 
 
 

 

12 Do you wish to request a separate election of a member of the board of directors, under the terms of article 141, paragraph 4, II, of Law 6,404, of 1976? (The shareholder can only fill this field in case of keeping the position of voting shares ininterrupted for 3 months prior to the general meeting. If the shareholder chooses “no” or “abstain”, his/her shares will not be computed for the request of a separate election of a member of the board of directors). APPROVALS - 11,004,910 1.6% 0.0% 4.6%
REJECTIONS - 1,085,733 0.2% 0.0% 0.5%
ABSTENTIONS - 16,547,143 2.4% 0.0% 7.0%
13 If it is found that neither the holders of voting shares nor the holders of preferred shares without voting rights or with restricted voting rights have complied, respectively, with the quorum required in items I and II of paragraph 4 of article 141 of Law No. 6,404, of 1976, you wish that your vote be aggregated to the votes of the shares with voting rights in order to elect the candidate to the board of directors with the highest number of votes among all those who, appearing on this remote ballot paper, run for election separately? APPROVALS - 26,731,239 3.9% 0.0% 11.3%
REJECTIONS - 923,761 0.1% 0.0% 0.4%
ABSTENTIONS - 2,431,719 0.4% 0.0% 1.0%
 
6 
 
 

 

14³ Replacement of effective and alternate members of the Company's Fiscal Council. APPROVALS 438,762,275 129,887,310 83.8% 99.4% 54.8%
REJECTIONS - 7,712,198 1.1% 0.0% 3.3%
ABSTENTIONS - 442,068 0.1% 0.0% 0.2%

 

 

¹²³ As a result of adjustments to the proposals (a) to amend the Bylaws, in order to reflect the First Amendment to the Shareholders’ Agreement, and (b) regarding the candidates appointed by FIP for the replacement of members of the Fiscal Council, as set forth in the Notice to Shareholders released by the Company on June 8, 2026, remote voting instructions that had been previously submitted in relation to what was included in the Management Proposal released on April 28, 2026 were disregarded, corresponding to: (i) 2,828,193 common shares and 15,103,418 preferred shares in item 1; (ii) 2,828,193 common shares and 15,103,418 preferred shares in item 2; and (iii) 2,828,193 common shares and 15,103,418 preferred shares in item 14.

 

 

 

 
7 
 
 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: June 8, 2026

  BRASKEM S.A.
       
       
  By:      /s/     Felipe Montoro Jens
     
    Name: Felipe Montoro Jens
    Title: Chief Financial Officer

 

DISCLAIMER ON FORWARD-LOOKING STATEMENTS

 

This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.


 

 

 

FAQ

What did Braskem (BAK) shareholders approve at the June 8, 2026 meetings?

Shareholders approved wide-ranging bylaw amendments, consolidating the bylaws and aligning them with a new Shareholders' Agreement and governance practices. They also authorized synchronizing the Executive Board’s term with the Board of Directors’ term.

How strong was support for Braskem (BAK) bylaw wording improvements in item 1?

The resolution to amend numerous bylaw articles for wording consistency received approvals corresponding to 84.9% of share capital. Rejections and abstentions were minimal, signaling broad investor support for technical and cross-reference adjustments.

What governance changes tied to the new Shareholders’ Agreement did Braskem (BAK) approve?

Shareholders approved amendments reflecting the new Shareholders’ Agreement, revising rules for the general meeting, Board of Directors, Executive Board and incorporating finance, strategy, people and safety committees into the bylaws as statutory bodies.

Did Braskem (BAK) investors back aligning executive terms with the board term?

Yes. Investors approved authorizing the Board of Directors to end the current Executive Board term early and start a new two-year term, so executive mandates coincide with the board term that began after the April 29, 2026 annual meeting.

How much support was there for cumulative voting requests at Braskem (BAK)?

Support for requesting cumulative voting for the Board of Directors was modest. The approvals represented a small fraction of share capital, while larger portions of shares either rejected the request or abstained from the cumulative voting question.

What does the Form 6-K say about Braskem (BAK) forward-looking statements?

The filing states that forward-looking statements are based on management’s current views and subject to many risks. It highlights uncertainties related to a geological event in Alagoas, related legal proceedings and the impact of the COVID-19 pandemic.